Literature DB >> 600963

Long term follow up of IgA mesangial deposits glomerulonephritis.

E Imbasciati, G Colasanti, G B di Belgioioso, G Banfi, A Durante, A Ragni, C Ponticelli, L Minetti, G D'Amico.   

Abstract

The clinical course of IgA Mesangial Deposits Glomerulonephritis (MDGN) has been investigated in 178 patients for 1 to 32 years (mean 6 years) from the onset of symptoms. Impairment of renal function occurred in 28 patients, 13 of whom required RDT or died in uraemia. Hypertension was observed in 67 patients. The actuarial survival rate at ten years was 91%. A significant correlation was observed between the occurrence of renal failure and the following features: absence of episodes of gross haematuria, early appearance of hypertension, marked proteinuria and sclerosing glomerular lesions. These data suggest that IgA MDGN has generally a very prolonged course, but in a few cases may evolve, sometimes early, to chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 600963

Source DB:  PubMed          Journal:  Proc Eur Dial Transplant Assoc        ISSN: 0071-2736


  5 in total

Review 1.  Experimental IgA nephropathy: factors influencing IgA-immune complex deposition in the glomerulus.

Authors:  A Chen; C H Wei; W H Lee; C Y Lin
Journal:  Springer Semin Immunopathol       Date:  1994

2.  Mesangial IgA nephropathy.

Authors:  P S Kincaid-Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-12

3.  IGA mesangial glomerulonephritis; significance and pathogenesis of segmental-focal glomerular lesions.

Authors:  G Syré
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

4.  Follow-up of renal function and urinary protein excretion in childhood IgA nephropathy.

Authors:  U B Berg; U C Widstam-Attorps
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

5.  Urinary protein excretion and renal function in children with IgA nephropathy.

Authors:  U C Widstam-Attorps; U B Berg
Journal:  Pediatr Nephrol       Date:  1991-05       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.